Summary & Overview
HCPCS G0141: Cervical/Vaginal Automated Cytology Screening with Manual Rescreen
HCPCS Level II code G0141 represents an automated screening cytopathology smear of the cervix or vagina that includes manual rescreening and requires physician interpretation. This code captures a hybrid workflow combining automated specimen review with human oversight, an approach increasingly used to improve screening throughput and maintain diagnostic accuracy. Nationally, G0141 is relevant for laboratories, pathology services, and clinicians involved in cervical cancer screening programs.
Key payers addressed in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of the code’s clinical role, typical sites of service, and the types of benchmarks and policy considerations that commonly apply to laboratory cytology services. The publication summarizes coding context, common modifier usage (provided separately), and how G0141 fits alongside related cytopathology services.
The report highlights performance and billing benchmarks, payer coverage considerations, and any recent policy or coding guidance affecting automated cytology screening with manual rescreen. It provides clinical context for when automated-plus-manual screening workflows are used and what operational stakeholders should note about documentation and physician interpretation requirements. Data not available in the input are identified as such in relevant sections.
Billing Code Overview
HCPCS Level II code G0141 describes a screening cytopathology smear of the cervix or vagina performed by an automated system with manual rescreening and physician interpretation. The service is a laboratory cytopathology screening procedure in which an automated preparatory and/or screening platform is used to evaluate cervical or vaginal smears, followed by a manual rescreening step that requires interpretation by a physician.
-
Service type: Laboratory screening cytopathology with automated screening and manual physician rescreen
-
Typical site of service: Clinical laboratory or pathology/laboratory department where cervical or vaginal cytology specimens are processed and interpreted
Clinical & Coding Specifications
Clinical Context
A 34-year-old woman presents to her primary care clinic for routine cervical cancer screening. A clinician obtains a cervical specimen using a cytobrush and spatula, and the sample is prepared as a conventional smear or liquid-based cytology slide. The laboratory processes the slide using an automated cytology screening system which prescreens slides for potential abnormal cells. Slides flagged by the automated system undergo manual rescreening by a cytotechnologist, and any slides requiring physician interpretation are forwarded to a pathologist or cytopathologist for final review and diagnostic interpretation. The typical workflow includes specimen collection in the office or outpatient clinic, transport to the pathology laboratory, automated prescreening, manual rescreening, and professional interpretation. Typical site of service: outpatient clinic or physician office for specimen collection and commercial or hospital-based pathology laboratory for automated screening and physician interpretation. Common clinical indications include routine cervical cancer screening, follow-up of an abnormal prior Pap test, evaluation of post-coital bleeding, or surveillance in patients with prior cervical dysplasia.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when reporting only the physician interpretation component separate from the technical component performed by the laboratory. |